Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model

Journal of Vascular Surgery

Volumn 42, Issue 1, 2005, Pages 140-148

  Deatrick, Kristopher B ^a   Eliason, Jonathan L ^a   Lynch, Erin M ^a   Moore, Andrea J ^a   Dewyer, Nicholas A ^a   Varma, Manu R ^a   Pearce, Charles G ^a   Upchurch Jr , Gilbert R ^a   Wakefield, Thomas W ^a   Henke, Peter K ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; PLASMINOGEN ACTIVATOR INHIBITOR; PROCOLLAGEN; UROKINASE RECEPTOR;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ENZYME ACTIVITY; FIBROSIS; GENE EXPRESSION; INFERIOR CAVA VEIN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOGENESIS; THROMBUS; VASCULAR SURGERY; VEIN LIGATION; VEIN WALL; WESTERN BLOTTING; WOUND HEALING; ZYMOGRAPHY;

ANIMALS; BLOTTING, WESTERN; COLLAGEN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GLYCOSAMINOGLYCANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; PLASMINOGEN ACTIVATOR INHIBITOR 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION; URINARY PLASMINOGEN ACTIVATOR; VENA CAVA, INFERIOR; VENOUS THROMBOSIS;

EID: 22044437578     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2005.04.014     Document Type: Article

References (41)

1. W.W. Coon, P.W. Willis, J.B. Keller Venous thromboembolism and other venous disease in the Tecumseh community health study Circulation 48 1973 839 846
2. M. Nordstrom, B. Lindblad, D. Bergqvist, T. Kjellstrom A prospective study of the incidence of deep-vein thrombosis within a defined population J Intern Med 232 1992 155 160
3. P. Prandoni, A.W. Lensing, A. Cogo The long term course of acute deep venous thrombosis Arch Intern Med 125 1996 1 7
4. K.T. Delis, D. Bountouroglou, A.O. Mansfield Venous claudication in iliofemoral thrombosis long-term effects on venous hemodynamics, clinical status and quality of life Ann Surg 239 2004 118 126
5. P.K. Henke, M. Varma, K.B. Deatrick, E.M. Lynch, A.J. Varga, D. Dubay Neutrophils modulate post-deep vein thrombosis vein wall fibrosis but not thrombus neovascularization (abstract) 2004 Society of University Surgeons Winter Park, FL
6. T.W. Wakefield, R.M. Strieter, C.A. Wilke, A.M. Kadell, S.K. Wrobleski, M.D. Burdick Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules Arterioscler Thromb Vasc Biol 15 1995 268 278
7. L.J. Downing, R.M. Strieter, A.M. Kadell, C.A. Wilke, J.C. Austin, B.D. Hare IL-10 regulates thrombus-induced vein wall inflammation and thrombosis J Immunol 161 1998 1471 1476
8. R. Visse, H. Nagase Matrix metalloproteinases and tissue inhibitors of metalloproteinases structure, function and biochemistry Circ Res 92 2003 827 839
9. Z.S. Galis, J.J. Khatri Matrix metalloproteinases in vascular remodeling and atherogenesis the good, the bad, and the ugly Circ Res 90 2002 251 262
10. R. Magid, T.J. Murphy, Z.S. Galis Expression of matrix metalloproteinase-9 in endothelial cells is differentially regulated by shear stress J Biol Chem 278 2003 32994 32999
11. V. Fontaine, M. Jacob, X. Houard, P. Rossingal, D. Plissonier, E. Angles-Cano Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms Am J Pathol 161 2002 1701 1710
12. H. Nagase Activation mechanisms of matrix metalloproteinases Biol Chem 1997 151 160
13. G. Murphy, F. Willenbrock, T. Crabbe, M. O'Shea, R. Ward, S. Atkinson Regulation of matrix metalloproteinase activity Ann N Y Acad Sci 732 1994 31 41
14. G. Ailawadi, J.L. Eliason, G.R. Upchurch Jr Current concepts in the pathogenesis of abdominal aortic aneurysm J Vasc Surg 38 2003 584 588
15. S. Sartore, A. Chiavegato, E. Faggin, R. Franch, M. Puato, S. Ausoni Contribution of adventitial fibroblasts to neointima formation and vascular remodeling from innocent bystander to active participant Circ Res 89 2001 1111 1121
16. H. Koyama, M.A. Reidy Expression of extracellular matrix proteins accompanies lesion growth in a model of intimal reinjury Circ Res 82 1998 988 995
17. Z.S. Galis, G. Sukhova, M. Lark, P. Libby Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques J Clin Invest 94 1994 2493 2503
18. A. Farb, F.D. Kolodgie, J.-Y. Hwang, A.P. Burke, K. Tefera, D.K. Weber Extracellular matrix changes in stented human coronary arteries Circulation 110 2004 940 947
19. R.L. Geary, S.T. Nikkari, W.D. Wagner, J.K. Williams, M.R. Adams, R.H. Dean Wound healing a paradigm for lumen narrowing after arterial reconstruction J Vasc Surg 27 1998 96 108
20. P.K. Henke, L.A. DeBrunye, R.M. Strieter, J.S. Bromberg, M. Prince, A.M. Kadell Viral IL-10 gene transfer decreases inflammation and cell adhesion molecule expression in a rat model of venous thrombosis J Immunol 164 2000 2131 2141
21. T.W. Wakefield, M.J. Linn, P.K. Henke, A.M. Kadell, C.A. Wilke, S.K. Wrobleski Neovascularization during venous thrombus organization a preliminary study J Vasc Surg 30 1999 885 893
22. P.K. Henke, A.J. Varga, S. De, K.B. Deatrick, J.L. Eliason, D.A. Arenberg Deep vein thrombosis resolution is modulated by monocyte CXCR2-mediated activity in a mouse model Arterioscler Thromb Vasc Biol 24 2004 1130 1137
23. D.G. Ginzinger Gene quantification using real-time quantitative PCR an emerging technology hits the mainstream Exp Hematol 30 2002 503 512
24. G.R. Upchurch, J.W. Ford, S.J. Weiss, B.S. Knipp, D.A. Peterson, R.W. Thompson Nitric oxide inhibition increases matrix metalloproteinase-9 expression by rat aortic smooth muscle cells in vitro J Vasc Surg 34 2001 76 83
25. A. Strongin, I. Collier, G. Bannikov, B. Marmer, G. Grant, G. Goldberg Mechanism of cell-surface activation of 72-kDa type IV collagenase isolation of the activated form of the membrane metalloproteinase J Biol Chem 270 1995 5331 5338
26. H. Lijnen Plasmin and matrix metalloproteinases in vascular remodeling Thromb Haemost 86 2001 324 333
27. J. Abe, T. Urano, H. Konno, Y. Erhan, T. Tanaka, N. Nobuhiko Larger and more invasive colorectal carcinoma contains larger amounts of plasminogen activator inhibitor type 1 and its relative ratio over urokinase receptor correlates well with tumor size Cancer 86 1999 2602 2611
28. T. Nomiya, K. Nemoto, H. Miyachi, K. Fujimoto, C. Takahashi, K. Takeda Significance of plasminogen-activation system in the formation of macroscopic types and invasion in esophageal carcinoma Anticancer Res 22 2002 2913 2916
29. S.J. Weiss Tissue destruction by neutrophils New Engl J Med 320 1989 365 376
30. Z.S. Galis, M. Muszynski, G. Sukhova, E. Simon-Morrissey, E. Unemori, M. Lark Cytokine-stimulated human vascular smooth muscle cells synthesize a compliment of enzymes required for extracellular matrix digestion Circ Res 75 1994 181 189
31. Y. Shi, S. Patel, R. Nicolescu, W. Chung, P. Desrochers, A. Zalewski Role of matrix metalloproteinases and their tissue inhibitors in the regulation of coronary cell migration Arterioscler Thromb Vasc Biol 19 1999 1150 1155
32. I. Singh, K. Burnand, M. Collins Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice rescue by normal bone marrow-derived cells Circulation 107 2003 869 875
33. S. Konstantinides, K. Schafer, D.J. Loskutoff Do PAI-1 and vitronectin promote or inhibit neointima formation? Arterioscler Thromb Vasc Biol 22 2002 1943 1945
34. A. Luttun, F. Lupu, E. Storkebaum, M.F. Hoylaerts, L. Moons, J. Crawley Lack of plasminogen activator-1 promotes growth and abnormal matrix remodeling of advanced atherosclerotic plaques in apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 22 2002 499 505
35. T. Oda, Y.O. Jung, H.S. Kim, X. Cai, J.M. Lopez-Guisa, Y. Ikeda PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction Kidney Int 30 2001 587 596
36. K. Yamamoto, D.J. Loskutoff Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator J Clin Inves 97 1996 2440 2451
37. L. Camoin, R. Pannell, F. Anfosso, J.P. Lefevre, J. Sampol, V. Gurewich Evidence for the expression of urokinase-type plasminogen activator by human venous endothelial cells in vivo Thromb Haemost 80 1998 961 967
38. A. Singer, R. Clark Cutaneous wound healing New Engl J Med 341 1999 738 746
39. W.D. Coats Jr, P. Whittaker, D.T. Cheung, J.W. Currier, B. Han, D.P. Faxon Collagen content is significantly lower in restenotic versus nonrestenotic vessels after balloon angioplasty in the atherosclerotic rabbit model Circulation 95 1997 1293 1300
40. D. Grainger, P. Kemp, A. Liu, R. Lawn, J. Metcalfe Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice Nature 370 1994 460 462
41. R. Iozzo, J.D. SanAntonio Heparan sulfate proteoglycans heavy hitters in the angiogenesis arena J Clin Invest 108 2001 349 355